Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Breast cancer

Pinuccia Valagussa¹, Gianni Bonadonna

¹Istituto Nazionale Tumori via Venezian 1 20133 Milan Italy.

Cancer Chemotherapy and Biological Response Modifiers

|April 22, 2003

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies.

Nature communications·2025

Same author

Development and validation of a gene expression-based Breast Cancer Purity Score.

NPJ precision oncology·2024

Same author

The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024

Same author

Spatial predictors of immunotherapy response in triple-negative breast cancer.

Nature·2023

Same author

Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Same author

Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023